CytomX Therapeutics CTMX
NASDAQ CTMX
$2.56 -0.07 (-2.66%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Interest & Investment Income (2014 - 2026)

Updated

CytomX Therapeutics (CTMX) recorded Interest & Investment Income of $3.16 million in Q2 2026, up 168.0% from $1.18 million a year earlier and up 111.9% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Interest & Investment Income (2014 - 2026) Analysis & Trends

On a TTM basis, CytomX Therapeutics' Interest & Investment Income came in at $7.72 million as of Jun 30, 2026, up 51.3% year-over-year; for FY2025, it came in at $5.21 million, down 27.0% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $7.14 million in FY2024 (-27.5%), $9.84 million in FY2023 (+486.2%), $1.68 million in FY2022 (+558.0%) and $255,000 in FY2021 (-86.1%).
  • The Q2 2026 figure is the highest quarterly Interest & Investment Income in data going back to Q3 2014.
  • On a year-over-year basis, Interest & Investment Income has increased for three consecutive quarters, with growth averaging 6.4% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 902.7% in Q4 2022, against a decline of 65.0% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.49 million (Q1 2026), $1.48 million (Q4 2025) and $1.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 CytomX Therapeutics 557.82 Mn -399.84 Mn - 3.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.16 Mn
Mar 31, 2026 1.49 Mn
Dec 31, 2025 1.48 Mn
Sep 30, 2025 1.59 Mn
Jun 30, 2025 1.18 Mn
Mar 31, 2025 955,000.00
Dec 31, 2024 1.28 Mn
Sep 30, 2024 1.69 Mn
Jun 30, 2024 1.97 Mn
Mar 31, 2024 2.19 Mn
Dec 31, 2023 2.50 Mn
Sep 30, 2023 2.70 Mn
Jun 30, 2023 2.31 Mn
Mar 31, 2023 2.33 Mn
Dec 31, 2022 732,000.00
Sep 30, 2022 616,000.00
Jun 30, 2022 262,000.00
Mar 31, 2022 68,000.00
Dec 31, 2021 73,000.00
Sep 30, 2021 70,000.00
API Access

CytomX Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CTMX&period=max&api_key=YOUR_API_KEY